VC
VISTEON CORPORATION
Latest price
As of Oct 26, 2026, 5:28 PM EDT · Market data by Massive
Market cap
$1.9B
Volume
458.7K
Previous close
$76.37
Day range
$74.59 – $77.24
Listed
Jun 8, 2000
Coverage
5 articles
Price performance
Recent trading
Newsroom
Latest VC coverage
PreIPO Chosen to Raise $250M for SPiCE Fund II, Shortly After SPiCE Fund I Named Leading VC Fund of 2022 in Blockchain Ecosystem
[ad_1] BOCA RATON, Fla. – (NewMediaWire) – April 28, 2023 – (ACN Newswire) – PreIPO, a leading provider of innovative financial technology solutions, is pleased to announce a new partnership with SPiCE VC. This partnership will enable PreIPO to further expand its offerings and bring cutting-edge financial technology to a broader marke
Eloisa Marchesoni Launches Tokenomics.Agency, LTD; Debuts "Crypto Pills" and Several Supporting Web3 Community Thought Leadership Channels
[ad_1] The 25-Year-Old Tokenomics Engineer Scales Successful Personal Web3 Consultancy Practice Into a Thriving Small Agency; Special Focus on VC-Backed Projects New York, NY – (NewMediaWire) – December 09, 2022 – PhillComm Global today announced its client Eloisa Marchesoni, a leading global tokenomics engineer, has officially launched T
Jon Lindsay Phillips Launches Emerging Industries PR Agency PhillComm Global; Client Roster Includes Publicly Traded Enterprises, Hyper-Growth Startups, and VC Funds
[ad_1] NEW YORK, NY – (NewMediaWire) – March 14, 2022 – Today marks the arrival of PhillComm Global, an elite group of PR and marcom specialists working in today’s most fascinating and explosive industries. The integrated firm is the ultimate manifestation of CEO and founder Jon Lindsay Phillips’ decades-long pursuit of a best-in-class, ded
Novo bags €430M Staten buyout option to boost cardiovascular disease pipeline
[ad_1] Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million ($485 million) deal. The agreement gives Novo the chance to add an anti-apoC3 antibody treatment for abnormal lipid levels to its pipeline. Staten has quietly established itself in the Dutch biotech scene over the past four years. Over that time, ...
Interactive Map Displays Strength of Industry’s National Footprint
[ad_1] BIO’s biennial financial growth and jobs report focuses on the financial progress and nationwide footprint of the bioscience business. As the business’s go-to useful resource for efficiency, positioning and traits, this necessary reference device for advocacy and messaging demonstrates the worth of the business’s constant file of producing high-qualit